Clinical trial Recruiting at 1 site Observational Ages 18 and up

Preoperative NPAR and Post-Induction Hemodynamic Vulnerability in Major Oncologic Surgery

Official title: Preoperative Neutrophil Percentage-to-Albumin Ratio as a Predictor of Post-Induction Hemodynamic Vulnerability in Major Oncologic Surgery

Run by Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital · NCT07804706 · Data updated 2026-11-12

This study checks if the preoperative neutrophil percentage-to-albumin ratio (NPAR) can flag who might become hemodynamically unstable after anesthesia induction in adults having major cancer surgery.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorDr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Academic / other
Locations1 site (Ankara, Yeni̇mahalle)
StatusRecruiting
StartedSeptember 1, 2026
Main results expectedDecember 1, 2026
Study endsDecember 15, 2026
Registry record updatedSeptember 9, 2026
Trial IDNCT07804706 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 or older scheduled for elective major oncologic surgery under general anesthesia with available preoperative CBC and albumin measurements and standard hemodynamic monitoring.

Probably not a fit

Patients lacking preoperative lab data or who do not experience post-induction hemodynamic vulnerability may not derive direct benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational study will analyze routinely collected preoperative labs to calculate NPAR and relate it to hemodynamic vulnerability after induction of general anesthesia, within a 20-minute window before incision. No changes to anesthesia care or additional tests are introduced. Data will include demographics, ASA status, labs, induction details, fluids, and vasopressor use to identify associations between NPAR and post-induction instability. Approximately 220 adult patients undergoing elective major oncologic surgery will be enrolled using consecutive sampling. The study will classify participants by presence or absence of post-induction hemodynamic vulnerability and will not modify standard clinical management.

Why it matters

Potential benefit: If successful, NPAR could help clinicians anticipate which patients are at risk for post-induction hypotension and tailor perioperative care accordingly.

How similar studies have gone: Prior work has explored inflammatory and nutritional markers as predictors of perioperative risk, but this exact NPAR-post-induction vulnerability relationship is under investigation and not yet proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older
* Scheduled for elective major oncologic surgery
* Undergoing surgery under general anesthesia
* Availability of preoperative complete blood count and serum albumin -measurements
* Standard hemodynamic monitoring
* Provision of written informed consent for participation in the study

Exclusion Criteria:

* Age younger than 18 years
* Emergency surgery
* Preoperative hemodynamic instability
* Preoperative vasopressor or inotropic support
* Sepsis or active infection
* Hematologic malignancy
* Advanced cardiac, renal, or hepatic failure
* Pregnancy
* Missing preoperative laboratory data -Inability to complete the 20-minute post-induction evaluation period-

Where it's running

  • Dr. Abdurrahman Yurtaslan Ankara Oncology Hospital
    Ankara, Yeni̇mahalle, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.